Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Return on Equity (2021 - 2025)

Bioventus (BVS) has disclosed Return on Equity for 4 consecutive years, with 0.14% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity changed N/A year-over-year to 0.14%, compared with a TTM value of 0.14% through Dec 2025, changed N/A, and an annual FY2025 reading of 0.14%, changed N/A over the prior year.
  • Return on Equity was 0.14% for Q4 2025 at Bioventus, up from 0.05% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.16% in Q2 2021 and bottomed at 0.6% in Q3 2023.
  • Average Return on Equity over 4 years is 0.09%, with a median of 0.01% recorded in 2022.
  • The sharpest move saw Return on Equity dropped -11bps in 2022, then crashed -60bps in 2023.
  • Year by year, Return on Equity stood at 0.03% in 2021, then plummeted by -683bps to 0.16% in 2022, then tumbled by -109bps to 0.33% in 2023, then surged by 142bps to 0.14% in 2025.
  • Business Quant data shows Return on Equity for BVS at 0.14% in Q4 2025, 0.05% in Q3 2025, and 0.03% in Q2 2025.